PPIDT00037
Drug Information
| Name | Glucagon |
|---|---|
| Sequence | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
| DrugBank_ID | DB00040 |
| Type | biotech |
| Indication | Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.[L7634,L7637,L7640,L7643,L8519] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| — | — |
3 mg
|
| Powder | Nasal |
3 MG
|
| Powder | Nasal |
3 mg/1
|
| Powder | Nasal |
3 mg / container
|
| Powder | Nasal |
3.000 mg
|
| Injection, powder, for solution | Intramuscular; Intravenous; Subcutaneous |
1 mg/1mL
|
| Injection, powder, for solution | Parenteral |
1 MG
|
| Kit; powder, for solution | Intramuscular |
1 mg / vial
|
| Injection, powder, for solution | Parenteral |
1 mg/ml
|
| Injection, powder, for solution | Intramuscular; Subcutaneous |
|
| Injection, powder, for solution | Intramuscular; Intravenous; Subcutaneous |
1 mg/ml
|
| Injection, powder, for solution; kit | Intramuscular; Intravenous; Subcutaneous |
1 mg/1mL
|
| Injection, solution | Subcutaneous |
1 mg
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous; Subcutaneous |
100000 mg
|
| Injection, powder, lyophilized, for solution | Intramuscular; Intravenous |
1 mg/1mL
|
| Kit | Intramuscular; Intravenous |
|
| Kit | Intramuscular; Intravenous; Subcutaneous |
1 mg/1mL
|
| Kit; powder, for solution | Intramuscular; Intravenous; Subcutaneous |
1 mg / vial
|
| Powder, for solution | Intramuscular; Intravenous; Subcutaneous |
1 mg / mL
|
| Injection, solution | Subcutaneous |
0.5 mg/0.1mL
|
| Injection, solution | Subcutaneous |
1 mg/0.2mL
|
| Injection, solution | Subcutaneous |
0.5 mg
|
| Solution | Parenteral |
1.00 U
|
| Solution | Parenteral |
1 mg/1ml
|
Target Information